Implantable cardiac devices such as pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices have saved millions of lives. These devices rely on batteries to deliver life-sustaining electrical stimuli. However, conventional lithium-ion batteries have a finite lifespan—typically five to ten years—after which surgical replacement is required. Each replacement procedure carries risks of infection, bleeding, anesthesia complications, and device malfunction. For patients with multiple comorbidities, repeated surgeries significantly diminish quality of life and increase healthcare costs. The global burden of battery replacement surgeries is substantial; according to a 2022 review in the Journal of the American Heart Association, approximately one in four pacemaker patients will undergo at least one generator replacement within 10 years of implantation. This reality has driven urgent research into energy harvesting technologies that can power cardiac devices sustainably, eliminating the need for periodic battery exchanges.

The Need for Sustainable Power Solutions

Current battery technology, while reliable, presents inherent limitations. Beyond the finite lifespan, batteries occupy significant volume within the device, constrain miniaturization, and require hermetic sealing to prevent toxic electrolyte leakage. Moreover, battery chemistry degrades over time, leading to unpredictable end-of-life behavior. Sustainable energy harvesting—capturing ambient energy from the body or its environment—offers a paradigm shift. The goal is to create self-powered cardiac devices that operate for the patient’s lifetime without surgical intervention. Such systems would reduce morbidity, lower healthcare costs, and enable devices to be smaller and more comfortable. The energy requirements of modern pacemakers have decreased dramatically—many now consume only 5–10 microwatts—making harvesting a realistic possibility. By leveraging the body’s own mechanical, thermal, or fluidic energy, we can achieve a closed-loop, maintenance-free power supply.

Types of Energy Harvesting Technologies

Piezoelectric Harvesting

Piezoelectric materials generate electric charge in response to mechanical stress. In the cardiac context, the most obvious source of mechanical energy is the heartbeat itself—the cyclic contraction and relaxation of the myocardium. Researchers have developed flexible piezoelectric devices that can be attached to the heart surface (epicardium) or embedded in the pericardial sac. These devices convert the displacement and pressure waves of each heartbeat into electrical current. For example, a 2019 study by Dagdeviren and colleagues demonstrated a piezoelectric patch that generated up to 3.8 microwatts per square centimeter from porcine heart motion—sufficient to power a modern pacemaker. More recent prototypes using lead-based perovskite materials have achieved efficiencies approaching 10% mechanical-to-electrical conversion. Challenges include durability under millions of cycles, biocompatibility of the piezoelectric ceramics, and the need for flexible substrates that conform to the dynamic heart geometry. Current research focuses on lead-free alternatives such as potassium sodium niobate (KNN) and polyvinylidene fluoride (PVDF) polymers.

Thermal Harvesting

Thermoelectric generators (TEGs) exploit the temperature gradient between the body core and the skin surface to produce electricity via the Seebeck effect. The human body maintains a core temperature of about 37 °C, while the skin surface is typically 2–5 °C cooler, depending on ambient conditions. This gradient, though small, can be harnessed by thermoelectric modules placed subcutaneously. Early TEG designs for cardiac devices achieved power outputs of 10–30 microwatts, but modern advances in nanostructured thermoelectric materials—such as bismuth telluride (Bi₂Te₃) alloys and skutterudites—have improved figure-of-merit (ZT) values, enabling up to 100 microwatts under optimal conditions. Thermal harvesting is attractive because it is continuous and does not depend on motion, making it suitable for patients with low activity levels. However, the power output is highly sensitive to ambient temperature and patient physiology. Additionally, the TEG must be placed near the skin to maximize the gradient, which may conflict with device location. Hybrid systems combining thermal and piezoelectric harvesting are under investigation to provide more consistent power.

Electromagnetic Harvesting

Electromagnetic generators convert kinetic energy from blood flow or body motion into electricity via electromagnetic induction. In cardiac applications, the pulsatile blood flow in arteries and veins provides a consistent energy source. Micro-scale electromagnetic harvesters typically consist of a magnet moving relative to a coil, embedded within a flexible stent or implanted near a major vessel. A 2018 prototype from Rice University generated 10–15 microwatts from the expansion and contraction of a simulated artery. However, the efficacy in vivo is hampered by the low frequency of cardiac cycles (1–2 Hz) and the small displacement amplitudes. Alternative approaches use the motion of the heart itself relative to surrounding tissues; for instance, a floating magnet in a housing attached to the pericardium can induce current as the heart beats. Electromagnetic harvesting remains the least mature of the three main categories, primarily due to difficulty in miniaturization and the risk of electromagnetic interference with other implanted electronics. Nonetheless, research into high-permeability core materials and novel coil geometries continues to improve performance.

Current Research and Developments

Significant progress has been made in translating energy harvesting from concept to working prototypes. Several academic groups and medtech companies are at the forefront. At the University of Delaware, a team led by Dr. John X. J. Zhang developed a flexible piezoelectric nanogenerator that produces 1.6 microwatts from human heartbeat movements (Zhang et al., 2020, Advanced Functional Materials). In Europe, the Horizon 2020 project “Harvesting Energy from the Human Heart” has demonstrated a hybrid device that combines piezoelectric and triboelectric effects, achieving over 8 microwatts in animal models. Zynergy, a startup based in the UK, is testing an implantable thermoelectric generator that harvests from the temperature gradient between the heart and the chest wall; early clinical trials show stable power output of 12 microwatts over a 30-day implant period in sheep.

Meanwhile, researchers at the University of California, San Diego have developed a fully biodegradable triboelectric nanogenerator that can be implanted and absorb after its useful life (Ouyang et al., 2019, Nature Communications). Although not yet used for cardiac devices, this approach offers a path toward transient electronics that reduce long-term foreign-body risks. Companies such as Medtronic and Boston Scientific have also filed patents for integrated energy harvesting modules that could be incorporated into next-generation pacemakers. While no commercial product has yet reached the market, the pace of innovation suggests that a clinical-grade harvesting system is within five to ten years of approval.

Challenges and Future Directions

Consistent Power Output

A major hurdle for all harvesting technologies is the variability of the energy source. A patient’s heartbeat rate and contractility change with activity, sleep, and disease state. Piezoelectric and electromagnetic harvesters produce more power during exercise but may fall below the device’s threshold during rest. Thermal harvesters depend on ambient temperature and patient metabolism, which fluctuate. To ensure uninterrupted operation, energy must be stored in a small buffer capacitor or thin-film battery. Power management circuits with maximum power point tracking (MPPT) must be ultra-efficient to avoid wasting harvested energy. Hybrid harvesting systems—combining two or more methods—can smooth out variability; for example, a piezoelectric patch supplemented by a thermoelectric module may provide adequate power across a wider range of physiological states.

Integration and Biocompatibility

Integrating a harvester with existing cardiac implantable electronic devices (CIEDs) without increasing device size or compromising functionality is non-trivial. The harvester must be encapsulated in biocompatible materials (such as parylene-C or medical-grade silicone) to prevent inflammation or fibrosis. It must also withstand the harsh mechanical environment of the beating heart for decades—potentially over 1 billion cycles. Mechanical fatigue and delamination of piezoelectric films are common failure modes. Researchers are exploring self-healing polymers and nanomaterial reinforcements to improve longevity. Additionally, the electrical output must be conditioned to match the voltage and current requirements of the CIED, typically 1–3 V DC. An efficient rectifier and regulator circuit with minimal quiescent current is essential.

Regulatory and Clinical Pathways

Bringing an energy-harvesting cardiac device to market requires rigorous testing for safety, reliability, and efficacy. The U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) have not yet established specific guidelines for such novel power sources. Devices will likely need to demonstrate long-term biocompatibility (ISO 10993 standards), electromagnetic compatibility, and resistance to sterilization. Moreover, the harvester must not interfere with the CIED’s sensing or pacing functions. Clinical trials will need to evaluate power output in diverse patient populations over several years. Despite these obstacles, the potential benefits—eliminating replacement surgeries, reducing infection risk, and improving patient satisfaction—provide strong motivation for regulatory flexibility.

Implications for Patient Care

The successful commercialization of energy harvesting solutions will transform the management of cardiac rhythm disorders. Patients will no longer face the anxiety and inconvenience of impending battery replacements. For younger patients, who may need device support for decades, this is particularly transformative. Healthcare systems will benefit from reduced procedural costs—each pacemaker replacement costs approximately $20,000–$30,000 in the United States, not accounting for hospital stays and complications—leading to overall savings. Moreover, devices can be miniaturized further, enabling less invasive implantation techniques and potentially expanding eligibility to pediatric populations. Environmentally, eliminating disposable batteries reduces electronic waste. The shift toward self-powered implants aligns with broader trends in sustainable medical technology and personalized medicine.

A real-world example of progress can be seen in a 2021 study led by Dr. Zhong Lin Wang at Georgia Tech, who demonstrated a self-powered pacemaker using a triboelectric nanogenerator that harvested energy from the respiratory movements of the diaphragm (Zheng et al., 2021, Science Advances). That system powered a commercial pacemaker in a porcine model for days without additional batteries. Such proof-of-concept studies underscore the viability of the approach.

Conclusion

Energy harvesting represents a fundamental shift in how we power implantable cardiac devices. By tapping into the body’s own sources of motion, heat, and fluid flow, researchers are inching closer to a fully self-sufficient pacemaker or ICD. Piezoelectric, thermoelectric, and electromagnetic technologies each offer unique advantages and face distinct challenges. Hybrid platforms, combined with advanced power management and biocompatible materials, hold the greatest promise for clinical translation. While obstacles remain—particularly regarding reliability, miniaturization, and regulatory approval—the trajectory is clear: sustainable power for cardiac devices will soon become reality, improving outcomes and quality of life for millions of patients worldwide. Continued investment in research, interdisciplinary collaboration, and early engagement with regulatory bodies will accelerate this transformation.